These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 1994544

  • 1. IgM and IgG alloantibody production by splenocytes and deposition in rat renal allografts are decreased by donor-specific blood transfusion.
    Baldwin WM, Rhoton K, Sanfilippo F.
    Transplantation; 1991 Feb; 51(2):481-5. PubMed ID: 1994544
    [Abstract] [Full Text] [Related]

  • 2. IgG alloantibody responses to donor-specific blood transfusion in different rat strain combinations as a predictor of renal allograft survival.
    Wasowska B, Baldwin WM, Sanfilippo F.
    Transplantation; 1992 Jan; 53(1):175-80. PubMed ID: 1370737
    [Abstract] [Full Text] [Related]

  • 3. Association of donor-specific blood transfusion enhancement of rat renal allografts with accelerated development of antiidiotypic antibodies and reduced alloantibody responses.
    Downey WE, Baldwin WM, Sanfilippo F.
    Transplantation; 1990 Jan; 49(1):160-6. PubMed ID: 2301006
    [Abstract] [Full Text] [Related]

  • 4. The association of enhancement of renal allograft survival by donor-specific blood transfusion with host MHC-linked inhibition of IgG anti-donor class I alloantibody responses.
    Wasowska B, Baldwin WM, Howell DN, Sanfilippo F.
    Transplantation; 1993 Sep; 56(3):672-80. PubMed ID: 7692630
    [Abstract] [Full Text] [Related]

  • 5. IgM and IgG alloantibody responses to MHC class I and II following rat renal allograft rejection. Effects of transplantectomy and posttransplantation blood transfusion.
    Wray DW, Baldwin WM, Sanfilippo F.
    Transplantation; 1992 Jan; 53(1):167-74. PubMed ID: 1370736
    [Abstract] [Full Text] [Related]

  • 6. Evidence that pretransplant donor blood transfusion prevents rat renal allograft dysfunction but not the in situ cellular alloimmune or morphologic manifestations of rejection.
    Ruiz P, Coffman TM, Howell DN, Straznickas J, Scroggs MW, Baldwin WM, Klotman PE, Sanfilippo F.
    Transplantation; 1988 Jan; 45(1):1-7. PubMed ID: 3276038
    [Abstract] [Full Text] [Related]

  • 7. The effects of donor-specific blood transfusion enhancement of rat renal allografts on cytotoxic activity and phenotypes of peripheral blood lymphocytes, splenocytes, and graft-infiltrating cells.
    Wasowska B, Baldwin WM, Howell DN, Sanfilippo F.
    Transplantation; 1991 Feb; 51(2):451-9. PubMed ID: 1994542
    [Abstract] [Full Text] [Related]

  • 8. Different patterns of sensitization following renal allograft rejection in an inbred rat strain combination.
    Wray DW, Baldwin WM, Sanfilippo F.
    Transplantation; 1993 May; 55(5):1132-8. PubMed ID: 8497894
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Alloantibody and transferable suppressor activity induced by cyclosporine and blood transfusions in the rat.
    Jones MC, Power DA, Cunningham C, Stewart KN, Catto GR.
    Transplantation; 1988 Nov; 46(5):645-9. PubMed ID: 2973667
    [Abstract] [Full Text] [Related]

  • 12. The role of class I major histocompatibility complex antigens in prolonging the survival of hepatic allografts in the rat.
    Yamaguchi Y, Harland RC, Wyble C, Bollinger RR.
    Transplantation; 1989 Jan; 47(1):171-7. PubMed ID: 2643224
    [Abstract] [Full Text] [Related]

  • 13. Induction of allograft nonresponsiveness after intrathymic inoculation with donor class I allopeptides. I. Correlation of graft survival with antidonor IgG antibody subclasses.
    Mhoyan A, Cramer DV, Baquerizo A, Shirwan H.
    Transplantation; 1997 Dec 27; 64(12):1665-70. PubMed ID: 9422399
    [Abstract] [Full Text] [Related]

  • 14. The effect of FTY 720 on engraftment in a model of spontaneous allograft acceptance.
    Koshiba T, Van Damme B, Ji P, Sefrioui H, Rutgeerts O, Waer M, Pirenne J.
    Transpl Int; 2003 Jun 27; 16(6):383-90. PubMed ID: 12819868
    [Abstract] [Full Text] [Related]

  • 15. FcR blocking activity in serum of actively enhanced rat renal allograft recipients due to IgG anti-class II MHC alloantibody.
    Marshall HE, Bolton EM, Gracie JA, Cocker JE, Sandilands GP, Bradley JA.
    Immunology; 1990 Mar 27; 69(3):379-84. PubMed ID: 2312162
    [Abstract] [Full Text] [Related]

  • 16. Contrasting outcomes of donor-specific blood transfusion: effectiveness against cell-mediated but not antibody-mediated rejection.
    Yang CP, Shittu E, McManus B, Wood PJ, Bell EB.
    Transplantation; 1998 Sep 15; 66(5):639-45. PubMed ID: 9753346
    [Abstract] [Full Text] [Related]

  • 17. Complement contributes to the rejection of complete and class I major histocompatibility complex--incompatible cardiac allografts.
    Qian Z, Jakobs FM, Pfaff-Amesse T, Sanfilippo F, Baldwin WM.
    J Heart Lung Transplant; 1998 May 15; 17(5):470-8. PubMed ID: 9628565
    [Abstract] [Full Text] [Related]

  • 18. Experimental renal transplantation: IgG antibodies which bind to graft tubular epithelial cells cannot be detected in the serum of recipient rats after pre-operative transfusion of donor blood.
    Rajasekar MR, Kirby JA, Shenton BK, Proud G, Taylor RM.
    Int Arch Allergy Immunol; 1993 May 15; 102(4):327-34. PubMed ID: 8241795
    [Abstract] [Full Text] [Related]

  • 19. Protection of heart and rejection of lymphocyte allografts from the same donor in recipients of donor-specific transfusions.
    Jaskłowska-Englisz M, Olszewski WL, Maksymowicz M, Ziółkowska A.
    Ann Transplant; 1998 May 15; 3(1):28-33. PubMed ID: 9869895
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.